Back
Speaker illustration

undefined undefined undefined

Presentations

ATTRibute-CM: ITT sensitivity analysis and sub-analysis comparing acoramidis and placebo in stage 4 CKD

Event: Heart Failure 2024

Topic: Clinical

Session: Cardiomyopathies: present and future

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources